|
Volumn 118, Issue 5, 2000, Pages 1278-1285
|
Pharmacoeconomic evaluation of COPD
a b a c |
Author keywords
COPD; Ipratropium; Pharmacoeconomics; agonist
|
Indexed keywords
ANTIBIOTIC AGENT;
BETA ADRENERGIC RECEPTOR STIMULATING AGENT;
BRONCHODILATING AGENT;
IPRATROPIUM BROMIDE;
STEROID;
THEOPHYLLINE;
ADULT;
AGED;
ARTICLE;
CHRONIC OBSTRUCTIVE LUNG DISEASE;
COST OF ILLNESS;
DIAGNOSTIC TEST;
DISEASE CLASSIFICATION;
DISEASE SEVERITY;
DRUG COST;
FEMALE;
HEALTH CARE COST;
HEALTH CARE UTILIZATION;
HOSPITAL COST;
HUMAN;
LABORATORY TEST;
MAJOR CLINICAL STUDY;
MALE;
OXYGEN THERAPY;
PRIORITY JOURNAL;
TREATMENT OUTCOME;
|
EID: 0033739242
PISSN: 00123692
EISSN: None
Source Type: Journal
DOI: 10.1378/chest.118.5.1278 Document Type: Article |
Times cited : (236)
|
References (16)
|